<td class= (Institución)
   (Nuevo usuario)
Ayuda  | Contacto  |  Castellano English  

Dadun > Depósito Académico > CIMA (Centro de Investigación Médica Aplicada) > Área de Terapia génica y Hepatología > Vectores > DA - CIMA - Terapia génica y Hepatología - Vectores - Artículos de revista >

In vitro and in vivo comparative study of chimeric liver-specific promoters
Autor(es) : Kramer, M.G. (María Gabriela)
Barajas, M. (Miguel)
Razquin, N. (Nerea)
Berraondo, P. (Pedro)
Rodrigo, M. (Manuel)
Wu, C. (Catherine)
Qian, C. (Cheng)
Fortes, P. (Puri)
Prieto, J. (Jesús)
Palabras clave : Transcriptional targeting
Gene therapy
Liver-specific promoters
Hydrodynamics-based transfection
Long-term expression
Fecha incorporación: 2003
Editorial : Nature Publishing Group
Versión del editor: http://www.nature.com/mt/journal/v7/n3/full/mt200356a.html
ISSN: 1525-0024
Cita: Kramer MG, Barajas M, Razquin N, Berraondo P, Rodrigo M, Wu C, et al. In vitro and in vivo comparative study of chimeric liver-specific promoters. Mol Ther 2003 Mar;7(3):375-385.
Targeting therapeutic genes to the liver is essential to improve gene therapy protocols of hepatic diseases and of some hereditary disorders. Transcriptional targeting can be achieved using liver-specific promoters. In this study we have made chimeric constructs combining promoter and enhancer regions of the albumin, alpha 1-antitrypsin, hepatitis B virus core protein, and hemopexin genes. Tissue specificity, activity, and length of gene expression driven from these chimeric regulatory sequences have been analyzed in cultured cells from hepatic and nonhepatic origin as well as in mice livers and other organs. We have identified a collection of liver-specific promoters whose activities range from twofold to less than 1% of the CMV promoter in human hepatoma cells. We found that the best liver specificity was attained when both enhancer and promoter sequences of hepatic genes were combined. In vivo studies were performed to analyze promoter function during a period of 50 days after gene transfer to the mouse liver. We found that among the various chimeric constructs tested in this work, the alpha1-antitrypsin promoter alone or linked to the albumin or hepatitis B enhancers is the most potent in directing stable gene expression in liver cells.
Enlace permanente: http://hdl.handle.net/10171/23260
Aparece en las colecciones: DA - CIMA - Terapia génica y Hepatología - Vectores - Artículos de revista

Ficheros en este registro:
Fichero:  MolTher2003_7_3_375.pdf
Tamaño:  575,37 kB
Formato:  Adobe PDF
 Visualizar / Abrir 

Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.